Stockreport

NeuroSense Vice President of R&D Shiran Zimri, Ph.D. to Participate in the 3rd Annual ALS Drug Development Summit [Yahoo! Finance]

NeuroSense Therapeutics Ltd.  (NRSN) 
PDF severe neurodegenerative diseases, announces that Vice President of R&D, Dr. Shiran Zimri will be a key presenter at the ALS Drug Development Summit in Boston, Mass. on [Read more]